News

News

Discover the news of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials.

NEWSLETTER NOVEMBER 2020

News & Events

NEWSLETTERNOVEMBER 2020CLINICAL TRIAL NEWS BREAKFAST WEBINAR : DRUG DEVELOPMENT IN ONCOLOGY IN THE ERA OF PRECISION MEDICINE 19th NOVEMBER, 2020…

Read more

Epidemiology, Methodology, and Clinical Research in the midst of the COVID-19 pandemic

News & Events

Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country…

Read more

IDDI at Biomarker and Companion Diagnostics Virtual Conference

October 20, 2020 — October 23, 2020

News & Events

Leveraging next gen technologies beyond conventional biomarker drug discovery The emergence of the need for safety and efficacy of a…

Read more

IDDI Complimentary Breakfast Webinar

November 19, 2020

News & Events

Drug development in oncology in the era of precision medicine 08:30am – 09:30am (CET), 19th NOVEMBER, 2020 WATCH THE RECORDED…

Read more

Medicon Valley Alliance: Q&A Interview with Erik Falvey from IDDI

News & Events

Recently, Erik Falvey, our Senior Director of Business Development, shared his insights during a Q&A session with Medicon Valley Alliance,…

Read more

ECCRT and IDDI establish partnership for continuous development

News & Events

Press Release European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning…

Read more

SCDM 2020 Virtual Conference

September 13, 2020 — September 16, 2020

News & Events

Join IDDI and the CDM Industry Leaders at SCDM 2020 Virtual Conference  Discover how IDDI prepares data for FDA Submission and…

Read more

Meet us at the Knowledge For Growth virtual event

September 9, 2020 — September 10, 2020

News & Events

IDDI will have a virtual booth – Come and e-meet us! Join us and our expert Erik Falvey on September 9…

Read more

Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors

News & Events

Highlights We explored relapse-free survival (RFS) as a surrogate for overall survival (OS). We used data from the European Organisation…

Read more

IDDI published an editorial on non-inferiority trials

News & Events

‘Commentary on Bamat et al.’, Clinical Trials 1–2, July 15, 2020 Dr. Everardo Saad, MD and Dr. Marc Buyse, ScD,…

Read more